![Suresh R. Babu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suresh R. Babu
Keine laufenden Positionen mehr
Profil
Dr. Suresh R.
Babu is Vice President-Drug Product Development at Synta Pharmaceuticals Corp.
He received his undergraduate degree from the University of Bangalore and a doctorate degree from the University of Connecticut.
Ehemalige bekannte Positionen von Suresh R. Babu
Unternehmen | Position | Ende |
---|---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Ausbildung von Suresh R. Babu
University of Bangalore | Undergraduate Degree |
University of Connecticut | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Synta Pharmaceuticals Corp.
![]() Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |